secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2026-06-29T20:05:29+00:00
Accession:  0001193805-26-000882
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunic shareholders approve 6M share increase to equity plan, elect directors, ratify auditor
--------------------------------------------------------------------------------

- Amendment to 2019 Omnibus Equity Plan approved, increasing authorized shares by 6,000,000 to total 8,644,887.
- Michael Bonney, Thorvald Nagel, and Richard Rudick elected as Class III directors to serve until 2029.
- Baker Tilly US, LLP ratified as independent registered public accounting firm for fiscal year 2026.
- Plan amendment vote: 4,391,782 for, 1,361,843 against, 24,538 abstain, and 3,107,100 broker non-votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000882/0001193805-26-000882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380526000882/e665616_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-000882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer